Please login to the form below
lipodystrophy
This page shows the latest lipodystrophy news and features for those working in and with pharma, biotech and healthcare.
Safety issues dampen enthusiasm for Akcea's volanesorsen
The company is upbeat about the prospects for the drug, which is also being developed for familial partial lipodystrophy (FPL), another rare disease characterised by elevated triglyceride levels.
Latest news
-
Isis renamed Ionis to sidestep militant association
is in trials for familial chylomicronaemia syndrome and familial partial lipodystrophy.
-
R&D productivity takes off
lipodystrophy - now divested to Aegerion Pharmaceuticals - has been set at an eye-watering $325, 000 a year.
-
Sharing good diabetes practice in the NHS
In this case the judges decided that the National Severe Insulin Resistance Service, a new national clinical service for patients with severe insulin resistance and/or lipodystrophy, was a worthy winner
-
Nexium windfall lifts AZ in third quarter
Meanwhile, AZ also said it is selling Myalept (metreleptin), an approved drug for generalised lipodystrophy, to Aegerion Pharmaceuticals.
-
AZ gets limited approval for metreleptin in US
AZ gets limited approval for metreleptin in US. First FDA-backed treatment for rare disease lipodystrophy. ... The company stressed that metreleptin is not approved to treat the complications of lipodystrophy, such as liver disease, or for
More from news
Approximately 1 fully matching, plus 14 partially matching documents found.
Latest Intelligence
-
Choices, choices: the rapidly evolving HIV treatment landscape
Since the advent of ARVs, the life expectancy of HIV patients has increased to be on par with those unaffected; however, long-term side-effects associated with NRTIs include lipodystrophy, kidney
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and bebefits
-
Senior Medical Writer
-
Great salary and benefits
-
Scientific Director
-
Great salary and bebefits
- Account Manager – Med Comms – London
-
Salary TBC
-
Senior Programme Executive
-
Salary TBC
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
Subscribe to our email news alerts
PMHub
Ashfield
Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...
Latest intelligence
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
- The Holy Grail of HCP Access
- This is the data you need to gain access....
Quick links
Infographics
